16-89746890-T-C
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000135.4(FANCA):c.3349A>G(p.Arg1117Gly) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000592 in 1,555,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1117T) has been classified as Pathogenic.
Frequency
Consequence
NM_000135.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FANCA | NM_000135.4 | c.3349A>G | p.Arg1117Gly | missense_variant, splice_region_variant | 34/43 | ENST00000389301.8 | NP_000126.2 | |
FANCA | NM_001286167.3 | c.3349A>G | p.Arg1117Gly | missense_variant, splice_region_variant | 34/43 | NP_001273096.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FANCA | ENST00000389301.8 | c.3349A>G | p.Arg1117Gly | missense_variant, splice_region_variant | 34/43 | 1 | NM_000135.4 | ENSP00000373952 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000247 AC: 4AN: 162016Hom.: 0 AF XY: 0.0000234 AC XY: 2AN XY: 85356
GnomAD4 exome AF: 0.0000599 AC: 84AN: 1403024Hom.: 0 Cov.: 32 AF XY: 0.0000664 AC XY: 46AN XY: 692444
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74362
ClinVar
Submissions by phenotype
Fanconi anemia complementation group A Pathogenic:6
Pathogenic, no assertion criteria provided | curation | Leiden Open Variation Database | Feb 28, 2020 | Curator: Arleen D. Auerbach. Submitters to LOVD: Arleen D. Auerbach, Johan de Winter, Sue Richards. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Counsyl | Mar 14, 2017 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 15, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 31, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Jun 21, 2021 | FANCA c.3349A>G has been identified in multiple individuals with Fanconi anemia. This FANCA variant (rs149277003) is rare (<0.1%) in a large population dataset (gnomAD: 6/193422 total alleles; 0.003%; no homozygotes) and has been reported in ClinVar (Variation ID: 219752). Functional studies have suggested that p.Arg1117Gly affects multiple aspects of FANCA function including cellular localization and in vitro single strand annealing and strand exchange. We consider FANCA c.3349A>G to be pathogenic. - |
Fanconi anemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 1117 of the FANCA protein (p.Arg1117Gly). This variant is present in population databases (rs149277003, gnomAD 0.006%). This missense change has been observed in individuals with Fanconi anemia (PMID: 9371798, 22778927). ClinVar contains an entry for this variant (Variation ID: 219752). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change affects FANCA function (PMID: 10373536, 11739169, 24349332). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 29, 2022 | Published functional studies indicate that the variant allows FANCA mutant protein to bind FANCG in the cytoplasm but prevents translocation and accumulation in the nucleus, thereby blocking downstream events in the FA pathway (Garcia-Higuera et al., 2000; Yagasaki et al., 2001); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 22778927, 10373536, 24349332, 11739169, 11050007, 30057198, 16084127, 9371798, 31970404, 28678401) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at